Livzon Pharmaceutical Group discloses A-share buyback for cancellation

Livzon Pharmaceutical Group Holdings Limited released its Next Day Disclosure Report, indicating no change in its H-shares, with the number of issued shares remaining at 299,807,117 as of September 9, 2025.

The report highlighted extensive A-share repurchase activities by Livzon Pharmaceutical Group. On September 9, 2025, the company repurchased 73,200 A-shares through the Shenzhen Stock Exchange at prices ranging from RMB40.26 to RMB41.76 per share, totaling RMB2,999,721. These repurchased shares are intended for cancellation.

The company's A-share repurchase program has been ongoing, with multiple transactions documented from December 25, 2024, through September 9, 2025. The total number of issued A-shares remained at 604,293,313 as of September 9, 2025, prior to the cancellation of the repurchased shares.